Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KXD1 antisense RNA 1 (KXD1-AS1) is a human long non-coding RNA (lncRNA) gene identified by the accession numbers HGNC:56662 and NCBI Gene:128193285[1][5]. It is transcribed antisense to the KXD1 protein-coding gene but, as of current knowledge, no specific biological function, disease association, or clinical application has been described for KXD1-AS1. Like other antisense lncRNAs, it may have a role in the regulation of gene expression, possibly by hybridizing with its sense transcript and affecting transcription, mRNA stability, or translation[2]. There is currently no evidence to classify it as a therapeutic target or to identify any interacting drugs, known mechanisms of action, disease biomarker roles, or safety concerns[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on KXD1 antisense RNA 1 (KXD1-AS1).